Treatment of Fragile X Syndrome via Dopamine Enhancers and Glutamate Inhibitors

Treatment of Fragile X Syndrome via Dopamine Enhancers and Glutamate Inhibitors

FRAXA Awards $50,000 in 2011 and $50,000 in 2010 to Patricia Cogram, PhD for treatment of Fragile X syndrome via Dopamine Enhancers and Glutamate Inhibitors. This project aims to follow up our and others observations that the dopamine receptor is under expressed in the Fragile X syndrome and thus determine the effectiveness of targeted pharmacological treatments in Fragile X syndrome.

Read more